Assertion: tetanus's vaccine | /r/HasProperty | dtap
Facets:
value: often
type: TEMPORAL
Source sentences:
text: The CDC’s Advisory Committee on Immunization Practices (ACIP) currently recommends administration of a tetanus containing vaccine (DTaP) at two, four, and six months old; between 15 and 18 months old; and between four and six years old.
text: These vaccines are often called DTaP, Tdap, or Td.
text: That booster comes in the form of a vaccine called Td, but since immunity to pertussis also wears off during childhood, a weaker form of the pertussis vaccine has been added to the booster to make the vaccine Tdap.
text: These vaccines are often called DTaP, Tdap, or Td.
text: The CDC’s Advisory Committee on Immunization Practices (ACIP) currently recommends administration of a tetanus containing vaccine (DTaP) at two, four, and six months old; between 15 and 18 months old; and between four and six years old.
text: The CDC’s Advisory Committee on Immunization Practices (ACIP) currently recommends administration of a tetanus containing vaccine (DTaP) at two, four, and six months old; between 15 and 18 months old; and between four and six years old.
text: It is available with the diphtheria and pertussis vaccines in two formulations – the Diphtheria, Tetanus and Pertussis vaccine (DTaP) and the Tetanus, Diphtheria and Pertussis vaccine (Tdap).
text: Most people receive their first dose as children in the form of a combined vaccine called DTaP (diphtheria-tetanus-acellular pertussis).
text: Most people receive their first dose as children in the form of a combined vaccine called DTaP (diphtheria-tetanus-acellular pertussis).
text: These vaccines are called DTaP, and they aren’t given to older children or adults.
text: It is available with the diphtheria and pertussis vaccines in two formulations – the Diphtheria, Tetanus and Pertussis vaccine (DTaP) and the Tetanus, Diphtheria and Pertussis vaccine (Tdap).
text: There are also serious adverse effects associated with tetanus containing vaccines (DT, Td, DTaP, Tdap), including “redness, swelling and pain at the injection site; headache; fatigue, sore and swollen joints; muscle weakness; fever; chills; nausea; shock; neuropathy; convulsions; encephalopathy; paralysis; Guillain-Barre Syndrome (GBS); death.”3